Earning Preview: Ambarella this quarter’s revenue is expected to increase by 19.71%, and institutional views are cautious

Earnings Agent08-28

Abstract

Ambarella, Inc. will report its second quarter fiscal 2027 results on September 3, 2026 Post-Mkt; this preview outlines the latest market expectations, a review of the last reported quarter, the current quarter outlook, and aggregated institutional opinions.

Market Forecast

Based on the latest projections for the current quarter, Ambarella’s revenue is estimated at 107.75 million US dollars, implying a 19.71% year-over-year increase, with estimated non-GAAP EPS at 0.17 and estimated EBIT at 6.49 million US dollars, reflecting year-over-year growth of 217.82% and 491.41%, respectively; no specific company gross margin or net margin outlook was provided. Main business momentum is characterized by an expected sequential uptick in sales owing to improving orders and previously signaled demand normalization; within that, the most promising category is expected to contribute disproportionately to the quarter’s growth, with total revenue projected to rise 19.71% year over year to 107.75 million US dollars.

Last Quarter Review

In the last reported quarter (fiscal Q1 2027), Ambarella delivered revenue of 100.36 million US dollars, a gross profit margin of 58.38%, GAAP net loss attributable to the parent company of 18.09 million US dollars, a net profit margin of -18.03%, and adjusted EPS of 0.11, which grew 57.14% year over year. A notable financial highlight was a modest top-line beat versus internal or external projections, alongside a positive adjusted EPS surprise, while quarter-on-quarter net income growth declined by 10.09%. On the commercial side, management emphasized continued traction across core product lines; overall revenue expanded by 16.87% year over year to 100.36 million US dollars.

Current Quarter Outlook

Main business

The company guides to a return to growth this quarter on both the top line and adjusted profitability metrics, supported by anticipated order flow and a pickup from customers that had previously moderated purchasing cycles. The revenue estimate of 107.75 million US dollars suggests a meaningful rebound compared with the comparable period, with an implied year-over-year increase of 19.71%. The operating line is projected to inflect as well: EBIT is estimated at 6.49 million US dollars, which—if achieved—would mark a sharp improvement from the prior-year base. Adjusted EPS is forecast at 0.17, indicating significant year-over-year expansion of 217.82%, consistent with leverage from higher volumes and controlled operating expenses. While a formal gross margin outlook was not disclosed, the prior quarter’s 58.38% level provides a recent reference point, and the mix of higher-value solutions could help sustain favorable product margins even as the company prioritizes volume recovery. The net margin outlook likewise remains undisclosed; however, the guidance framework implies narrowed GAAP losses on higher revenue and higher gross profit dollars.

From a sequencing standpoint, management’s execution focus this quarter appears to be on converting pipeline into shipments and maintaining cost discipline to translate incremental revenue into adjusted profitability gains. Given the prior quarter’s negative GAAP net margin and the sequential contraction in net income, investors will scrutinize opex pacing, inventory turns, and working capital dynamics for signs of structurally improved cash conversion. The guidance embedded in the estimates, notably the significant year-over-year lift in EBIT and adjusted EPS, points to a potential step-up in operating leverage as sales volume recovers.

Most promising business

The most promising contribution to growth in the current quarter is expected to come from the company’s higher-value silicon and software offerings aligned with vision-based compute, where demand visibility and deal activity have improved relative to the trough. Though segment-level revenue was not disclosed in the prior quarter’s filings, the quarter’s total revenue is projected to increase by 19.71% year over year to 107.75 million US dollars, and company commentary has consistently suggested that the fastest-growing families of products collect a larger share of incremental bookings as customers refresh deployments. The economics of these solutions typically support margin durability due to value-added features and software enablement, which is consistent with the EBIT and EPS uplift implied in the projection.

Beyond the immediate quarter, the opportunity set for these solutions is conditioned by customer qualification cycles, integration timelines, and platform refresh cadences. The run-rate indicates improved pull from existing programs and new design wins moving into production, which should lift average selling prices and enhance blended margins if scale holds. The sustainability of this momentum through the fiscal year will depend on maintaining delivery schedules, broadening attach of software and firmware features that monetize beyond initial silicon, and preserving pricing discipline in the face of competitive promotions.

Key stock price drivers this quarter

Short-term stock performance is likely to hinge on three tangible factors. First, the degree of alignment between reported revenue, EBIT, and adjusted EPS and the market’s latest estimates—107.75 million US dollars in revenue, 6.49 million US dollars in EBIT, and 0.17 in EPS—will inform whether the current rebound narrative has a firm footing; any deviation will likely be magnified given the company’s recent volatility around guidance updates. Second, gross margin commentary will be critical: the prior quarter’s 58.38% level sets a baseline, and investors will look for evidence that product mix and cost controls can hold margins in the high-fifties despite scaling volumes. Third, corporate development headlines could exert an outsized influence on sentiment; merger or strategic alternatives chatter within the last two months elevated share volatility and may add a non-fundamental overlay to the stock into and through the print.

Additionally, the market will analyze the cadence of order intake and backlog conversion that underpins the 19.71% year-over-year revenue uplift estimate. Any incremental disclosures regarding channel inventory, supply chain lead times, or customer program ramps could recalibrate expectations for the second half of the fiscal year. Investors will also parse operating expense trends relative to revenue growth to gauge the durability of the expected 217.82% adjusted EPS growth, particularly as the company balances R&D investment for future platforms against near-term profitability commitments.

Analyst Opinions

Using reports and rating actions within the January 1, 2026 to August 27, 2026 window, the balance of institutional opinion trends cautious. Among identified updates, one Buy contrasts with two Holds and a negative near-term performance commentary following the first-quarter release and guidance, yielding an indicative split of roughly 33% bullish versus 67% cautious-to-bearish.

On the cautious side, Bank of America Securities reiterated a Hold rating with a price target of 72 US dollars, signaling balanced risk-reward pending greater evidence of sustained revenue acceleration and adjusted profitability improvements. Roth MKM maintained a Hold rating with a 90 US dollars target, reflecting a pragmatic wait-and-see stance toward execution against the rebound plan and the translation of backlog into revenue, particularly as cost controls and mix aim to support margins. The near-term skeptical tone was amplified in coverage that highlighted the stock’s pullback after the last quarterly update, citing soft sales guidance for the subsequent quarter as a key pressure point.

In synthesizing these cautions, the majority view concentrates on three themes relevant to the upcoming report. First, while the revenue estimate of 107.75 million US dollars and adjusted EPS estimate of 0.17 show a meaningful year-over-year lift, the durability of this trend is unproven and will need confirmation through both the print and the outlook commentary. Second, the prior quarter’s GAAP net margin of -18.03% and net loss of 18.09 million US dollars underscore that the path back to sustainable GAAP profitability remains a work in progress, making gross margin quality and operating expense control focal points for analysts. Third, with corporate development speculation in the background, analysts anticipate that any commentary on strategic options could overshadow fundamentals in the short run; nevertheless, they emphasize that the valuation reaction should ultimately revert to the trajectory of revenue, EBIT, and adjusted EPS if guidance visibility improves.

Within this framework, the cautious camp expects management to meet or modestly exceed the earnings algorithm embedded in the current estimates while guiding in a way that protects the improving narrative without overcommitting. The bar for upside appears centered on sustaining gross margins near the historical high-fifties and demonstrating that the projected 491.41% year-over-year increase in EBIT is not a one-off phenomenon but rather a function of enduring scale and mix enhancements. Conversely, any sign that the recovery is overly dependent on a narrow set of shipments, that backlog conversion is slipping, or that operating expenses need to re-accelerate to compete could reintroduce skepticism into the stock.

As a result, the consensus leaning is to remain prudent ahead of the print: the majority prefers clear evidence of sequential execution, stronger visibility in orders, and confirmation that adjusted profitability growth is tracking the estimates. This aligns with a measured stance on valuation until the company substantiates that the anticipated 19.71% revenue growth can compound into subsequent quarters and that the transition from adjusted profitability gains to improved GAAP metrics is underway. The cautious view therefore centers on validation of the key assumptions—revenue at 107.75 million US dollars, adjusted EPS at 0.17, and EBIT at 6.49 million US dollars—paired with credible guidance that implies continuity into the fiscal second half. In short, the market’s majority perspective seeks confirmation that the recovery indicated by the forecasts is both repeatable and scalable, with operating discipline protecting margins as revenue climbs.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment